Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments

C Marchetti, F De Felice, A Romito, V Iacobelli… - Seminars in Cancer …, 2021 - Elsevier
Ovarian cancer (OC) remains a fatal malignancy because most patients experience
recurrent disease, which is resistant to chemotherapy. The outcomes for patients with …

Molecular characterization of epithelial ovarian cancer: implications for diagnosis and treatment

V Rojas, KM Hirshfield, S Ganesan… - International journal of …, 2016 - mdpi.com
Epithelial ovarian cancer is a highly heterogeneous disease characterized by multiple
histological subtypes. Molecular diversity has been shown to occur within specific …

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

KC Wiegand, SP Shah, OM Al-Agha… - … England Journal of …, 2010 - Mass Medical Soc
Background Ovarian clear-cell and endometrioid carcinomas may arise from endometriosis,
but the molecular events involved in this transformation have not been described. Methods …

Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling

RL Chandler, JS Damrauer, JR Raab… - Nature …, 2015 - nature.com
Ovarian clear-cell carcinoma (OCCC) is an aggressive form of ovarian cancer with high
ARID1A mutation rates. Here we present a mutant mouse model of OCCC. We find that …

A brief review of the management of platinum-resistant–platinum-refractory ovarian cancer

B Oronsky, CM Ray, AI Spira, JB Trepel, CA Carter… - Medical oncology, 2017 - Springer
Ovarian cancer, which ranks fifth in cancer deaths among women, is the most lethal
gynecologic malignancy. Epithelial ovarian cancer (EOC) is the most common histologic …

Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010

MS Anglesio, MS Carey, M Köbel, H MacKay… - Gynecologic …, 2011 - Elsevier
OBJECTIVES: Recent literature has highlighted histological types of ovarian carcinoma as
distinct diseases, each with unique clinical and molecular features. Historically, the …

Clear cell carcinoma of the ovary: a review of the literature

MG Del Carmen, M Birrer, JO Schorge - Gynecologic oncology, 2012 - Elsevier
OBJECTIVE: Different histologic types of epithelial ovarian cancer may represent different
diseases with unique clinical and molecular characteristics. Clear cell carcinoma (CCC) of …

A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer

AK Nagaraja, CJ Creighton, Z Yu, H Zhu… - Molecular …, 2010 - academic.oup.com
MicroRNAs (miRNAs) are small noncoding RNAs that direct gene regulation through
translational repression and degradation of complementary mRNA. Although miRNAs have …

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

EP Samartzis, A Noske, KJ Dedes, D Fink… - International journal of …, 2013 - mdpi.com
Endometriosis is a common gynecological disease affecting 6%–10% of women of
reproductive age and is characterized by the presence of endometrial-like tissue in …

[HTML][HTML] The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density …

Y He, Q Zhu, M Chen, Q Huang, W Wang, Q Li… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Inconsistencies in the half-maximal (50%) inhibitory concentration (IC 50) data for anticancer
chemotherapeutic agents have yielded irreproducible experimental results and thus …